Nemes Rush Group’s GSK GSK Stock Holding History

Nemes Rush Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.86K	Hold	188	–	–	﹤0.01%	579
2026 Q1	$10.4K	Hold	188	–	–	﹤0.01%	543
2025 Q4	$9.22K	Buy	188 +98	+109%	+$4.57K	﹤0.01%	558
2025 Q3	$3.88K	Hold	90	–	–	﹤0.01%	566
2025 Q2	$3.46K	Hold	90	–	–	﹤0.01%	570
2025 Q1	$3.49K	Hold	90	–	–	﹤0.01%	565
2024 Q4	$3.04K	Buy	+90	New	+$3.24K	﹤0.01%	585
2024 Q2	–	Sell	-1,201	Closed	-$51.5K	–	635
2024 Q1	$51.5K	Hold	1,201	–	–	0.01%	269
2023 Q4	$44.5K	Hold	1,201	–	–	0.01%	267
2023 Q3	$43.5K	Sell	1,201 -150	-11%	-$5.32K	0.01%	267
2023 Q2	$48.1K	Buy	+1,351	New	+$48.5K	0.01%	267

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nemes Rush Group's GSK Position: Q2 2026 in Review

Nemes Rush Group held its GSK (GSK) position steady in Q2 2026 at 188 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 11 quarters since. The position peaked at $51.5K in Q1 2024. 1,041 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Nemes Rush Group held 188 shares of GSK worth $9.86K as of Q2 2026.
Nemes Rush Group left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #579 holding.
Nemes Rush Group first reported a position in GSK in Q2 2023 and has held it in 11 quarters since.
Nemes Rush Group's GSK position peaked at $51.5K in Q1 2024.
1,041 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.